Pacific Biosciences of California (PACB) — Cash Flow Reinvestment Rate
Pacific Biosciences of California (PACB) has a Cash Flow Reinvestment Rate of 0.72x as of March 2020, reinvesting $54.33 Million (capex $117.00K plus investments $-54.21 Million) from operating cash flow of $75.36 Million. Explore PACB capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Biosciences of California Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Pacific Biosciences of California across 1 annual periods. Also explore Pacific Biosciences of California total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pacific Biosciences of California (2020–2020)
Year-by-year capital reinvestment analysis for Pacific Biosciences of California. For live market cap and broader valuation context, see PACB market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 11.25x | $219.32 Million | $19.50 Million | $1.04 Million | — |